Boryung

Boryung Current Liabilities

The Current Liabilities of Boryung (003850.KS) as of Oct 30, 2026 is 123.84 B KRW. In the previous year, Current Liabilities was 182.10 B KRW — a change of -32.00% (lower).

Current Liabilities

123.84 BKRW

YoY

-32.00%

Last updated:

Current Liabilities of Boryung is 2025 123.84 B KRW. Current Liabilities of Boryung was 2024 182.10 B KRW. It decreases by -32.00% lower compared to the previous year.

The Boryung Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
132.45 B KRW
Jan 1, 2019
149.21 B KRW
Jan 1, 2020
112.63 B KRW
Jan 1, 2021
145.17 B KRW
Jan 1, 2022
264.17 B KRW
Jan 1, 2023
126.03 B KRW
Jan 1, 2024
182.10 B KRW
Jan 1, 2025
123.84 B KRW
The Boryung Current Liabilities history
YEARCurrent LiabilitiesYoY
123.84 BKRW-32.00%
182.10 BKRW+44.50%
126.03 BKRW-52.29%
264.17 BKRW+81.97%
145.17 BKRW+28.90%
112.63 BKRW-24.52%
149.21 BKRW+12.66%
132.45 BKRW+13.98%
116.20 BKRW-40.97%
196.86 BKRW+64.88%
119.40 BKRW+35.97%
87.81 BKRW-2.29%
89.87 BKRW+54.81%
58.05 BKRW+8.40%
53.55 BKRW-43.75%
95.20 BKRW+99.22%
47.78 BKRW+25.93%
37.95 BKRW+4.97%
36.15 BKRW-5.90%
38.42 BKRW-7.71%
41.62 BKRW-7.69%
45.09 BKRW+0.55%
44.85 BKRW+12.54%
39.85 BKRW-2.18%
40.74 BKRW+66.55%
24.46 BKRW-18.99%
30.20 BKRW-16.43%
36.13 BKRW-23.89%
47.47 BKRW+15.57%
41.08 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boryung Stock analysis

What does Boryung do? Boryung Corp is a South Korean company that was founded in 1963 and is headquartered in Seoul. The founders are In-Bum Kim and Myung-Chul Kang. The company is very successful in the pharmaceutical and cosmetic industries. It has a leading position in the prescription drug market and has also specialized in the development and marketing of over-the-counter products. History: Boryung Corp has experienced impressive growth in various areas over the past decades. The company's original focus was the production of pharmaceutical products for the local healthcare industry. Thanks to hard work and large investments, Boryung began to succeed in international markets for pharmaceutical products. The company expanded its business operations by establishing a branch for cosmetic products as well as food and beverage production. Business model: Boryung Corp's business model is based on marketing medical products for domestic and international markets, as well as developing and marketing cosmetics and dietary supplements. The company sells its products under various brands, including Valtocin (for high blood pressure), Eumosone (for skin conditions), and Rapithon (for colds). The company aims to make its brands synonymous with quality and effectiveness in the markets where it operates. Various divisions: Boryung Corp has various divisions and subsidiaries specializing in different categories of products. The company operates a branch for cosmetic products (known as K-beauty). Notable cosmetic brands of Boryung include Mizon (skin care products), AHC (high-quality cosmetics), and Ryo (hair care series). The company also produces high-quality food and beverages, including soy products, instant noodles, and energy drinks. Products: Boryung offers a wide range of products, including prescription drugs, over-the-counter medications, consumer goods, and cosmetics. The company's prescription drugs are in high demand and include a wide range of products such as antibiotics, antidiabetic drugs, antihypertensives, as well as medications for skin diseases, cancer, and diabetes. Boryung is also very active in product-related research and development, investing a significant portion of its revenue in research and development. Conclusion: Boryung Corp has repeatedly proven over the years that it is an extremely versatile and successful company operating in a variety of business sectors. The company has established a strong position in the prescription drug and cosmetic product markets and is also involved in other business areas. Through continuous research and development of new products and the expansion of existing product lines, the company is driving its growth forward. Boryung is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boryung stock

Current Liabilities of Boryung is 123.84 B KRW in 2025.

Current Liabilities of Boryung changed from 182.10 B KRW to 123.84 B KRW, representing a -32.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Boryung since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Boryung historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Boryung

All Key Metrics — Boryung